TP-06 for Corneal Ulcer
(Capellion Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Capellion is a Phase 2 trial comparing TP-06 2.0% with Vehicle in up to 32 adults with persistent corneal epithelial defects. Participants will receive treatment for 8 weeks and be followed for 2 additional weeks to assess corneal healing and safety.
Are You a Good Fit for This Trial?
This trial is for adults with persistent corneal epithelial defects (a type of non-healing sore on the surface of the eye).Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- TP-06
Trial Overview
The study compares TP-06 eye drops (2.0%) to a placebo (vehicle) in up to 32 adults. Participants use the treatment for 8 weeks, then are monitored for another 2 weeks to check healing and safety.
How Is the Trial Designed?
2
Treatment groups
Active Control
Placebo Group
Find a Clinic Near You
Who Is Running the Clinical Trial?
Tarsus Pharmaceuticals, Inc.
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.